FDA Grants Priority Review for Kura Oncology, Inc. (KURA) and Kyowa Kirin’s Ziftomenib
The U.S. Food and Drug Administration (FDA) accepted the New Drug Application (NDA) for ziftomenib, an investigational treatment pursued by Kura Oncology, Inc.
Posts Tagged ‘NASDAQ:KURA’
Kura Oncology, Inc. (NASDAQ:KURA) Q1 2025 Earnings Call Transcript
Kura Oncology, Inc. (NASDAQ:KURA) Q1 2025 Earnings Call Transcript May 1, 2025Kura Oncology, Inc. misses on earnings expectations.
Kura Oncology, Inc. (NASDAQ:KURA) Q4 2024 Earnings Call Transcript
Operator: Good day, everyone, and welcome to today's Q4 2024 Kura Oncology, Inc. Financial Results Conference Call. At this time, all participants are in a listen-only mode.
10 Best Small-Cap Biotech Stocks with Massive Potential According to Hedge Funds
The biotechnology sector is expanding quickly due to rising demand for novel therapies, technological advances, and government assistance.
10 Most Promising Cancer Stocks According to Hedge Funds
According to the World Health Organization (WHO), cancer remains one of the leading causes of death globally, responsible for nearly 10 million deaths in 2020, or about one in...
Kura Oncology, Inc. (NASDAQ:KURA) Q3 2024 Earnings Call Transcript
Operator: Good afternoon, ladies and gentlemen. Welcome to the Kura Oncology Third Quarter 2024 Financial Results Call.
10 Best Small-Cap Healthcare Stocks To Buy Now
In difficult economic times, healthcare equities are sometimes regarded as a defensive investment.
Kura Oncology, Inc. (NASDAQ:KURA) Q2 2024 Earnings Call Transcript
Operator: Good day, and welcome to the Q2 2024 Kura Oncology Conference Call. [Operator Instructions] Please note this event is being recorded.
Kura Oncology, Inc. (NASDAQ:KURA) Q1 2024 Earnings Call Transcript
Operator: Good afternoon, ladies and gentlemen, and welcome to the Q1 2024 Kura Oncology Financial Results Conference Call.
Kura Oncology, Inc. (NASDAQ:KURA) Q4 2023 Earnings Call Transcript
Kura Oncology, Inc. beats earnings expectations. Reported EPS is $-0.55, expectations were $-0.56. Kura Oncology, Inc.
5 Most Promising Cancer Stocks According to Analysts
In this piece, we will take a look at the five most promising cancer stocks according to analysts.
Kura Oncology, Inc. (NASDAQ:KURA) Q3 2023 Earnings Call Transcript
Operator: Good afternoon, ladies and gentlemen, and welcome to the Third Quarter 2023 Kura Oncology Inc. Earnings Conference Call.
14 Best Cancer Stocks To Buy Now
In this article, we discuss 14 best cancer stocks to buy.
5 Best U.S. Stocks to Buy Now Under $10
In this article, we will discuss the 5 best U.S. stocks to buy now under $10. If you want to explore similar stocks, you can also take a look at 15 Best U.S.
Kura Oncology, Inc. (NASDAQ:KURA) Q2 2023 Earnings Call Transcript
Operator: Good afternoon, ladies and gentlemen, and welcome to the Q2 2023 Kura Oncology, Inc. Earnings Conference Call. At this time, all lines are in listen-only mode.
Kura Oncology, Inc. (NASDAQ:KURA) Q1 2023 Earnings Call Transcript
Operator: Good afternoon, ladies and gentlemen, and welcome to the Q1 2023 Kura Oncology, Inc. Earnings Conference Call. [Operator Instructions].
Kura Oncology, Inc. (NASDAQ:KURA) Q4 2022 Earnings Call Transcript
Operator: Greetings, and welcome to Kura Oncology's Fourth Quarter 2022 Earnings Conference Call. At this time, all participants are in a listen-only mode.
10 Small-Cap Growth Stocks Hedge Funds Love
Madison Square Garden Sports Corp. (NYSE:MSGS), Boyd Gaming Corporation (NYSE:BYD), and Chegg, Inc.
Did The Smart Money Play Kura Oncology, Inc. (KURA) Correctly?
Stocks, especially the once high flying technology stocks, had a lousy start to the new year. QQQ lost 9% of its value in January.
Here is What Hedge Funds Think About Kura Oncology, Inc. (KURA)
Before we spend countless hours researching a company, we like to analyze what insiders, hedge funds and billionaire investors think of the stock first.
10 Pharmaceutical Stocks to Buy According to Brandon Haley’s Holocene Advisors
In this article, we take a look at the 10 pharmaceutical stocks to buy according to Brandon Haley’s Holocene Advisors.
Is Kura Oncology, Inc. (KURA) A Good Stock To Buy?
A whopping number of 13F filings filed with U.S.
Is KURA Stock A Buy or Sell?
Before we spend countless hours researching a company, we like to analyze what insiders, hedge funds and billionaire investors think of the stock first.
Is KURA A Good Stock To Buy According To Hedge Funds?
Our extensive research has shown that imitating the smart money can generate significant returns for retail investors, which is why we track nearly 817 active prominent money ...
Hedge Funds Never Been This Bullish On Kura Oncology, Inc. (KURA)
We know that hedge funds generate strong, risk-adjusted returns over the long run, which is why imitating the picks that they are collectively bullish on can be a profitable strategy...
Did Hedge Funds Make The Right Call On Kura Oncology, Inc. (KURA) ?
Insider Monkey has processed numerous 13F filings of hedge funds and successful value investors to create an extensive database of hedge fund holdings.
Hedge Funds Aren’t Done Buying Kura Oncology, Inc. (KURA)
At the end of February we announced the arrival of the first US recession since 2009 and we predicted that the market will decline by at least 20% in (Recession is Imminent: We...
Kura Oncology, Inc. (KURA): Hedge Funds Can’t Make Up Their Minds
We are still in an overall bull market and many stocks that smart money investors were piling into surged through the end of November.
Hedge Funds Have Never Been This Bullish On Kura Oncology, Inc. (KURA)
We are still in an overall bull market and many stocks that smart money investors were piling into surged through October 17th.
Is Kura Oncology, Inc. (KURA) A Good Stock To Buy?
"Since 2006, value stocks (IVE vs IVW) have underperformed 11 of the 13 calendar years and when they beat growth, it wasn't by much.
Here’s What Hedge Funds Think About Kura Oncology, Inc. (KURA)
Hedge funds and other investment firms run by legendary investors like Israel Englander, Jeffrey Talpins and Ray Dalio are entrusted to manage billions of dollars of accredited...
Kura Oncology, Inc. (KURA): Are Hedge Funds Right About This Stock?
The government requires hedge funds and wealthy investors with over a certain portfolio size to file a report that shows their positions at the end of every quarter.
13G Filing: EcoR1 Capital and Kura Oncology Inc (KURA)
You can access the original SEC filing by clicking here.
13G Filing: Great Point Partners and Kura Oncology Inc (KURA)
You can access the original SEC filing by clicking here.
A Look Into Latest Developments Surrounding Yahoo!, Kura Oncology, Kohl’s and Other Stocks
Among the stocks on the move today are Yahoo! Inc.
Have a Look at Hedge Funds’ Recent Moves in These Three Stocks
There is no doubt that some hedge funds’ 13F filings disclose rich trading ideas, but these filings are generally considered delayed and irrelevant.
